Arcus Biosciences (RCUS) PT Lowered to $42 at Citi
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $30.34 +2.78%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Arcus Biosciences (NYSE: RCUS) to $42.00 (from $48.00) while maintaining a Buy rating.
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Navios Maritime Partners (NMM) PT Raised to $100 at Jefferies
- Ross Stores, Inc. (ROST) PT Raised to $272 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
